When you linking your Twitter Account Market Wire News Trending Stocks news and your Portfolio Stocks News will automatically tweet from your Twitter account.
Be alerted of any news about your stocks and see what other stocks are trending.
HTBX - Heat Biologics soars 14% on completion of ZVX-60 vaccine cell line for COVID-19
Heat Biologics Inc.
Heat Biologics (HTBX) rises 14% premarket after completing its gp96-based COVID-19 vaccine cell line ("ZVX-60"), being developed for use as either a standalone, or in combination with other vaccines to enhance prophylactic protection.Data, generated at the University of Miami Miller School of Medicine, has confirmed expression of gp96, OX40L and Spike protein.Also, preparations for manufacturing the vaccine are well underway.